Third, evidence published since the guidelines reveals
that health care-associated pneumonia criteria are a poor
predictor of patients with drug-resistant pneumonia patients.12,31
Extraneous administration of broad spectrum an tibiotics
leads to increased adverse events, increased costs,
and increased bacterial resistance.